INTEGRATED BIOPHARMA INC (INBP) › Total LiabilitiesINTEGRATED BIOPHARMA INC (INBP) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $21.34M2012: $22.26M2013: $22.90M2014: $21.74M2015: $20.94M2016: $22.28M2017: $21.12M2018: $19.80M2019: $17.90M2020: $16.88M2021: $11.11M2022: $6.67M2023: $6.57M2024: $6.97M2025: $4.58M$4.58M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$4.58M-34.2%2024$6.97M+6.1%2023$6.57M-1.6%2022$6.67M-39.9%2021$11.11M-34.2%2020$16.88M-5.7%2019$17.90M-9.6%2018$19.80M-6.3%2017$21.12M-5.2%2016$22.28M+6.4%2015$20.94M-3.7%2014$21.74M-5.1%2013$22.90M+2.9%2012$22.26M+4.3%2011$21.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share